# Serum Insulin Response After Acute and Chronic Sucralose Ingestion in Healthy Volunteers With Variable Body Mass Index

> **NCT03703141** · NA · COMPLETED · sponsor: **Hospital General de México Dr. Eduardo Liceaga** · enrollment: 95 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** sucralose 48 mg (splenda)/day for ten weeks

## Key facts

- **NCT ID:** NCT03703141
- **Lead sponsor:** Hospital General de México Dr. Eduardo Liceaga
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-27
- **Primary completion:** 2018-06-04
- **Final completion:** 2018-06-04
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2018-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03703141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03703141, "Serum Insulin Response After Acute and Chronic Sucralose Ingestion in Healthy Volunteers With Variable Body Mass Index". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03703141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*